Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.

Clin Cancer Res

Department of Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, USA.

Published: February 2003

Download full-text PDF	Source

Publication Analysis

matrix metalloproteinases

metalloproteinases angiogenesis

angiogenesis cancer

cancer commentary

commentary lockhart

lockhart reduction

reduction wound

wound angiogenesis

angiogenesis patients

patients treated

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!